Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Aug;65(8):3239–3247. doi: 10.1128/iai.65.8.3239-3247.1997

Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages.

C A Salkowski 1, G R Detore 1, S N Vogel 1
PMCID: PMC175458  PMID: 9234781

Abstract

Monophosphoryl lipid A (MPL) is a nontoxic derivative of the lipid A region of lipopolysaccharide (LPS) that is being developed as both an adjuvant and prophylactic drug for septic shock. We compared the ability of LPS and MPL to induce interleukin-10 (IL-10), IL-12 p35, IL-12 p40, gamma interferon (IFN-gamma), glucocorticoid receptor (GR), IL-1 receptor antagonist (IL-1ra), and inducible nitric oxide synthase mRNA expression in murine peritoneal macrophages. These genes were chosen for their ability to positively or negatively regulate the host immune response and thus for their potential involvement in MPL-induced adjuvanticity or in its ability to protect against sepsis. LPS was a more potent inducer of IL-12 p35, IL-12 p40, and IFN-gamma mRNA, as well as of IL-12 protein, than MPL. In contrast, MPL induced higher levels of IL-10 mRNA than did LPS from 1 to 1,000 ng/ml. In general, MPL was not a more potent inducer of negative regulatory genes, since MPL and LPS induced similar levels of GR and IL-1ra mRNA. Addition of anti-IL-10 antibody to cultures increased the induction of MPL-induced IL-12 p35, IL-12 p40, and IFN-gamma mRNA, suggesting that the enhanced production of IL-10 by MPL-stimulated macrophages contributes to decreased production of mRNA for IL-12 (p35 and p40) and IFN-gamma. Conversely, the addition of exogenous IL-10 to LPS-treated macrophages reduced the mRNA expression of these cytokine genes. These studies suggest that enhanced production of IL-10 by MPL-stimulated macrophages may contribute to the reduced toxicity of MPL through its negative action on induction of cytokines shown to enhance endotoxicity.

Full Text

The Full Text of this article is available as a PDF (381.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astiz M. E., Galera A., Saha D. C., Carpati C., Rackow E. C. Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor. Shock. 1994 Oct;2(4):271–274. doi: 10.1097/00024382-199410000-00007. [DOI] [PubMed] [Google Scholar]
  2. Astiz M. E., Rackow E. C., Still J. G., Howell S. T., Cato A., Von Eschen K. B., Ulrich J. T., Rudbach J. A., McMahon G., Vargas R. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med. 1995 Jan;23(1):9–17. doi: 10.1097/00003246-199501000-00006. [DOI] [PubMed] [Google Scholar]
  3. Astiz M. E., Saha D. C., Brooks K., Carpati C. M., Rackow E. C. Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Circ Shock. 1993 Mar;39(3):194–198. [PubMed] [Google Scholar]
  4. Astiz M. E., Saha D. C., Carpati C. M., Rackow E. C. Induction of endotoxin tolerance with monophosphoryl lipid A in peritonitis: importance of localized therapy. J Lab Clin Med. 1994 Jan;123(1):89–93. [PubMed] [Google Scholar]
  5. Berg D. J., Kühn R., Rajewsky K., Müller W., Menon S., Davidson N., Grünig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995 Nov;96(5):2339–2347. doi: 10.1172/JCI118290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  7. Bone R. C. Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev. 1993 Jan;6(1):57–68. doi: 10.1128/cmr.6.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Car B. D., Eng V. M., Schnyder B., Ozmen L., Huang S., Gallay P., Heumann D., Aguet M., Ryffel B. Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med. 1994 May 1;179(5):1437–1444. doi: 10.1084/jem.179.5.1437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carozzi S., Salit M., Cantaluppi A., Nasini M. G., Barocci S., Cantarella S., Lamperi S. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1989 Aug;27(8):1748–1753. doi: 10.1128/jcm.27.8.1748-1753.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chomarat P., Rissoan M. C., Banchereau J., Miossec P. Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med. 1993 Feb 1;177(2):523–527. doi: 10.1084/jem.177.2.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cohen L., Haziot A., Shen D. R., Lin X. Y., Sia C., Harper R., Silver J., Goyert S. M. CD14-independent responses to LPS require a serum factor that is absent from neonates. J Immunol. 1995 Dec 1;155(11):5337–5342. [PubMed] [Google Scholar]
  12. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993 Sep 1;178(3):1041–1048. doi: 10.1084/jem.178.3.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Danielsen M., Northrop J. P., Ringold G. M. The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins. EMBO J. 1986 Oct;5(10):2513–2522. doi: 10.1002/j.1460-2075.1986.tb04529.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Deepe G. S., Jr, Taylor C. L., Harris J. E., Bullock W. E. Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2. Infect Immun. 1986 Jul;53(1):6–12. doi: 10.1128/iai.53.1.6-12.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Di Marzio P., Puddu P., Conti L., Belardelli F., Gessani S. Interferon gamma upregulates its own gene expression in mouse peritoneal macrophages. J Exp Med. 1994 May 1;179(5):1731–1736. doi: 10.1084/jem.179.5.1731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Doherty G. M., Lange J. R., Langstein H. N., Alexander H. R., Buresh C. M., Norton J. A. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol. 1992 Sep 1;149(5):1666–1670. [PubMed] [Google Scholar]
  17. Eigler A., Moeller J., Endres S. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J Immunol. 1995 Apr 15;154(8):4048–4054. [PubMed] [Google Scholar]
  18. Evans G. F., Zuckerman S. H. Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance. Eur J Immunol. 1991 Sep;21(9):1973–1979. doi: 10.1002/eji.1830210902. [DOI] [PubMed] [Google Scholar]
  19. Fahmi H., Charon D., Mondange M., Chaby R. Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production. Infect Immun. 1995 May;63(5):1863–1869. doi: 10.1128/iai.63.5.1863-1869.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Fischer E., Marano M. A., Van Zee K. J., Rock C. S., Hawes A. S., Thompson W. A., DeForge L., Kenney J. S., Remick D. G., Bloedow D. C. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992 May;89(5):1551–1557. doi: 10.1172/JCI115748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fluckiger A. C., Garrone P., Durand I., Galizzi J. P., Banchereau J. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med. 1993 Nov 1;178(5):1473–1481. doi: 10.1084/jem.178.5.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Freudenberg M. A., Keppler D., Galanos C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun. 1986 Mar;51(3):891–895. doi: 10.1128/iai.51.3.891-895.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fultz M. J., Barber S. A., Dieffenbach C. W., Vogel S. N. Induction of IFN-gamma in macrophages by lipopolysaccharide. Int Immunol. 1993 Nov;5(11):1383–1392. doi: 10.1093/intimm/5.11.1383. [DOI] [PubMed] [Google Scholar]
  24. GELLER P., MERRILL E. R., JAWETZ E. Effects of cortisone and antibiotics on lethal action of endotoxins in mice. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):716–719. doi: 10.3181/00379727-86-21211. [DOI] [PubMed] [Google Scholar]
  25. Geller D. A., de Vera M. E., Russell D. A., Shapiro R. A., Nussler A. K., Simmons R. L., Billiar T. R. A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J Immunol. 1995 Nov 15;155(10):4890–4898. [PubMed] [Google Scholar]
  26. Grunvald E., Chiaramonte M., Hieny S., Wysocka M., Trinchieri G., Vogel S. N., Gazzinelli R. T., Sher A. Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect Immun. 1996 Jun;64(6):2010–2018. doi: 10.1128/iai.64.6.2010-2018.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gustafson G. L., Rhodes M. J. Effects of tumor necrosis factor and dexamethasone on the regulation of interferon-gamma induction by monophosphoryl lipid A. J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):129–133. doi: 10.1097/00002371-199402000-00006. [DOI] [PubMed] [Google Scholar]
  28. Gustafson G. L., Rhodes M. J., Hegel T. Monophosphoryl lipid A as a prophylactic for sepsis and septic shock. Prog Clin Biol Res. 1995;392:567–579. [PubMed] [Google Scholar]
  29. Gérard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 1993 Feb 1;177(2):547–550. doi: 10.1084/jem.177.2.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Heinzel F. P., Rerko R. M., Ling P., Hakimi J., Schoenhaut D. S. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun. 1994 Oct;62(10):4244–4249. doi: 10.1128/iai.62.10.4244-4249.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Heinzel F. P. The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol. 1990 Nov 1;145(9):2920–2924. [PubMed] [Google Scholar]
  32. Henricson B. E., Benjamin W. R., Vogel S. N. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect Immun. 1990 Aug;58(8):2429–2437. doi: 10.1128/iai.58.8.2429-2437.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Henricson B. E., Manthey C. L., Perera P. Y., Hamilton T. A., Vogel S. N. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect Immun. 1993 Jun;61(6):2325–2333. doi: 10.1128/iai.61.6.2325-2333.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Henricson B. E., Perera P. Y., Qureshi N., Takayama K., Vogel S. N. Rhodopseudomonas sphaeroides lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid A. Infect Immun. 1992 Oct;60(10):4285–4290. doi: 10.1128/iai.60.10.4285-4290.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Heremans H., Van Damme J., Dillen C., Dijkmans R., Billiau A. Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med. 1990 Jun 1;171(6):1853–1869. doi: 10.1084/jem.171.6.1853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kitchens R. L., Ulevitch R. J., Munford R. S. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med. 1992 Aug 1;176(2):485–494. doi: 10.1084/jem.176.2.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kohler J., Heumann D., Garotta G., LeRoy D., Bailat S., Barras C., Baumgartner J. D., Glauser M. P. IFN-gamma involvement in the severity of gram-negative infections in mice. J Immunol. 1993 Jul 15;151(2):916–921. [PubMed] [Google Scholar]
  38. Ling P., Gately M. K., Gubler U., Stern A. S., Lin P., Hollfelder K., Su C., Pan Y. C., Hakimi J. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol. 1995 Jan 1;154(1):116–127. [PubMed] [Google Scholar]
  39. MacMicking J. D., Nathan C., Hom G., Chartrain N., Fletcher D. S., Trumbauer M., Stevens K., Xie Q. W., Sokol K., Hutchinson N. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995 May 19;81(4):641–650. doi: 10.1016/0092-8674(95)90085-3. [DOI] [PubMed] [Google Scholar]
  40. Madonna G. S., Peterson J. E., Ribi E. E., Vogel S. N. Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A. Infect Immun. 1986 Apr;52(1):6–11. doi: 10.1128/iai.52.1.6-11.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Manthey C. L., Perera P. Y., Salkowski C. A., Vogel S. N. Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol. 1994 Jan 15;152(2):825–831. [PubMed] [Google Scholar]
  42. McIntire F. C., Sievert H. W., Barlow G. H., Finley R. A., Lee A. Y. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry. 1967 Aug;6(8):2363–2372. doi: 10.1021/bi00860a011. [DOI] [PubMed] [Google Scholar]
  43. Myers K. R., Beining P., Betts M., Snippe H., Inman J., Golding B. Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in mice. Infect Immun. 1995 Jan;63(1):168–174. doi: 10.1128/iai.63.1.168-174.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Neta R., Oppenheim J. J., Schreiber R. D., Chizzonite R., Ledney G. D., MacVittie T. J. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med. 1991 May 1;173(5):1177–1182. doi: 10.1084/jem.173.5.1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ozmen L., Pericin M., Hakimi J., Chizzonite R. A., Wysocka M., Trinchieri G., Gately M., Garotta G. Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med. 1994 Sep 1;180(3):907–915. doi: 10.1084/jem.180.3.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Randow F., Syrbe U., Meisel C., Krausch D., Zuckermann H., Platzer C., Volk H. D. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med. 1995 May 1;181(5):1887–1892. doi: 10.1084/jem.181.5.1887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rudbach J. A., Myers K. R., Rechtman D. J., Ulrich J. T. Prophylactic use of monophosphoryl lipid A in patients at risk for sepsis. Prog Clin Biol Res. 1994;388:107–124. [PubMed] [Google Scholar]
  49. Salkowski C. A., Detore G., McNally R., van Rooijen N., Vogel S. N. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J Immunol. 1997 Jan 15;158(2):905–912. [PubMed] [Google Scholar]
  50. Salkowski C. A., Neta R., Wynn T. A., Strassmann G., van Rooijen N., Vogel S. N. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J Immunol. 1995 Sep 15;155(6):3168–3179. [PubMed] [Google Scholar]
  51. Salkowski C. A., Vogel S. N. Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity. J Immunol. 1992 Dec 15;149(12):4041–4047. [PubMed] [Google Scholar]
  52. Sarawar S. R., Carding S. R., Allan W., McMickle A., Fujihashi K., Kiyono H., McGhee J. R., Doherty P. C. Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion. Reg Immunol. 1993 May-Aug;5(3-4):142–150. [PubMed] [Google Scholar]
  53. Skeen M. J., Miller M. A., Shinnick T. M., Ziegler H. K. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol. 1996 Feb 1;156(3):1196–1206. [PubMed] [Google Scholar]
  54. Snijders A., Hilkens C. M., van der Pouw Kraan T. C., Engel M., Aarden L. A., Kapsenberg M. L. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol. 1996 Feb 1;156(3):1207–1212. [PubMed] [Google Scholar]
  55. Svetić A., Finkelman F. D., Jian Y. C., Dieffenbach C. W., Scott D. E., McCarthy K. F., Steinberg A. D., Gause W. C. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol. 1991 Oct 1;147(7):2391–2397. [PubMed] [Google Scholar]
  56. Szabó C., Thiemermann C., Wu C. C., Perretti M., Vane J. R. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):271–275. doi: 10.1073/pnas.91.1.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Takayama K., Qureshi N., Ribi E., Cantrell J. L. Separation and characterization of toxic and nontoxic forms of lipid A. Rev Infect Dis. 1984 Jul-Aug;6(4):439–443. doi: 10.1093/clinids/6.4.439. [DOI] [PubMed] [Google Scholar]
  58. Ulrich J. T., Myers K. R. Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. Pharm Biotechnol. 1995;6:495–524. [PubMed] [Google Scholar]
  59. Wynn T. A., Eltoum I., Oswald I. P., Cheever A. W., Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med. 1994 May 1;179(5):1551–1561. doi: 10.1084/jem.179.5.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wysocka M., Kubin M., Vieira L. Q., Ozmen L., Garotta G., Scott P., Trinchieri G. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol. 1995 Mar;25(3):672–676. doi: 10.1002/eji.1830250307. [DOI] [PubMed] [Google Scholar]
  61. Yao Z., Foster P. A., Gross G. J. Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation. Circ Shock. 1994 Jul;43(3):107–114. [PubMed] [Google Scholar]
  62. Zuckerman S. H., Shellhaas J., Butler L. D. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol. 1989 Feb;19(2):301–305. doi: 10.1002/eji.1830190213. [DOI] [PubMed] [Google Scholar]
  63. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 Nov 1;174(5):1209–1220. doi: 10.1084/jem.174.5.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. van der Poll T., Marchant A., Buurman W. A., Berman L., Keogh C. V., Lazarus D. D., Nguyen L., Goldman M., Moldawer L. L., Lowry S. F. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 1995 Dec 1;155(11):5397–5401. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES